221 related articles for article (PubMed ID: 24176052)
1. Effect of metallo-β-lactamase production and multidrug resistance on clinical outcomes in patients with Pseudomonas aeruginosa bloodstream infection: a retrospective cohort study.
Willmann M; Kuebart I; Marschal M; Schröppel K; Vogel W; Flesch I; Markert U; Autenrieth IB; Hölzl F; Peter S
BMC Infect Dis; 2013 Nov; 13():515. PubMed ID: 24176052
[TBL] [Abstract][Full Text] [Related]
2. Metallo-beta-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones.
Juan C; Zamorano L; Mena A; Albertí S; Pérez JL; Oliver A
J Antimicrob Chemother; 2010 Mar; 65(3):474-8. PubMed ID: 20071364
[TBL] [Abstract][Full Text] [Related]
3. The influence of metallo-beta-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections.
Zavascki AP; Barth AL; Gonçalves AL; Moro AL; Fernandes JF; Martins AF; Ramos F; Goldani LZ
J Antimicrob Chemother; 2006 Aug; 58(2):387-92. PubMed ID: 16751638
[TBL] [Abstract][Full Text] [Related]
4. Increased prevalence and clonal dissemination of multidrug-resistant Pseudomonas aeruginosa with the blaIMP-1 gene cassette in Hiroshima.
Kouda S; Ohara M; Onodera M; Fujiue Y; Sasaki M; Kohara T; Kashiyama S; Hayashida S; Harino T; Tsuji T; Itaha H; Gotoh N; Matsubara A; Usui T; Sugai M
J Antimicrob Chemother; 2009 Jul; 64(1):46-51. PubMed ID: 19398456
[TBL] [Abstract][Full Text] [Related]
5. Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes.
Lucena A; Dalla Costa LM; Nogueira KS; Matos AP; Gales AC; Paganini MC; Castro ME; Raboni SM
J Hosp Infect; 2014 Aug; 87(4):234-40. PubMed ID: 25027563
[TBL] [Abstract][Full Text] [Related]
6. First outbreak of VIM-2 metallo-β-lactamase-producing Pseudomonas aeruginosa in The Netherlands: microbiology, epidemiology and clinical outcomes.
Van der Bij AK; Van Mansfeld R; Peirano G; Goessens WH; Severin JA; Pitout JD; Willems R; Van Westreenen M
Int J Antimicrob Agents; 2011 Jun; 37(6):513-8. PubMed ID: 21497065
[TBL] [Abstract][Full Text] [Related]
7. Dissemination of Pseudomonas aeruginosa producing SPM-1-like and IMP-1-like metallo-beta-lactamases in hospitals from southern Brazil.
Martins AF; Zavascki AP; Gaspareto PB; Barth AL
Infection; 2007 Dec; 35(6):457-60. PubMed ID: 18034208
[TBL] [Abstract][Full Text] [Related]
8. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-{beta}-lactamase in a teaching hospital in southern Brazil.
Zavascki AP; Gaspareto PB; Martins AF; Gonçalves AL; Barth AL
J Antimicrob Chemother; 2005 Dec; 56(6):1148-51. PubMed ID: 16239284
[TBL] [Abstract][Full Text] [Related]
9. Detection of VIM-2-, IMP-1- and NDM-1-producing multidrug-resistant Pseudomonas aeruginosa in Malaysia.
Liew SM; Rajasekaram G; Puthucheary SD; Chua KH
J Glob Antimicrob Resist; 2018 Jun; 13():271-273. PubMed ID: 29432937
[TBL] [Abstract][Full Text] [Related]
10. Emergence of a novel multidrug-resistant Pseudomonas aeruginosa strain producing IMP-type metallo-β-lactamases and AAC(6')-Iae in Japan.
Kitao T; Tada T; Tanaka M; Narahara K; Shimojima M; Shimada K; Miyoshi-Akiyama T; Kirikae T
Int J Antimicrob Agents; 2012 Jun; 39(6):518-21. PubMed ID: 22483560
[TBL] [Abstract][Full Text] [Related]
11. Occurrence of VIM-4 metallo-β-lactamase-producing Pseudomonas aeruginosa in an Algerian hospital.
Merradi M; Kassah-Laouar A; Ayachi A; Heleili N; Menasria T; Hocquet D; Cholley P; Sauget M
J Infect Dev Ctries; 2019 Apr; 13(4):284-290. PubMed ID: 32045372
[TBL] [Abstract][Full Text] [Related]
12. [Molecular epidemiology of beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates].
Er H; Altındiş M; Aşık G; Demir C
Mikrobiyol Bul; 2015 Apr; 49(2):156-65. PubMed ID: 26167816
[TBL] [Abstract][Full Text] [Related]
13. Nosocomial spread of Pseudomonas aeruginosa producing the metallo-beta-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications.
Peña C; Suarez C; Tubau F; Gutierrez O; Domínguez A; Oliver A; Pujol M; Gudiol F; Ariza J
Clin Microbiol Infect; 2007 Oct; 13(10):1026-9. PubMed ID: 17651449
[TBL] [Abstract][Full Text] [Related]
14. Carbapenemase-producing Pseudomonas aeruginosa from central Greece: molecular epidemiology and genetic analysis of class I integrons.
Liakopoulos A; Mavroidi A; Katsifas EA; Theodosiou A; Karagouni AD; Miriagou V; Petinaki E
BMC Infect Dis; 2013 Oct; 13():505. PubMed ID: 24168643
[TBL] [Abstract][Full Text] [Related]
15. Metallo-β-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type.
Van der Bij AK; Van der Zwan D; Peirano G; Severin JA; Pitout JD; Van Westreenen M; Goessens WH;
Clin Microbiol Infect; 2012 Sep; 18(9):E369-72. PubMed ID: 22805614
[TBL] [Abstract][Full Text] [Related]
16. Spread of extensively resistant VIM-2-positive ST235 Pseudomonas aeruginosa in Belarus, Kazakhstan, and Russia: a longitudinal epidemiological and clinical study.
Edelstein MV; Skleenova EN; Shevchenko OV; D'souza JW; Tapalski DV; Azizov IS; Sukhorukova MV; Pavlukov RA; Kozlov RS; Toleman MA; Walsh TR
Lancet Infect Dis; 2013 Oct; 13(10):867-76. PubMed ID: 23845533
[TBL] [Abstract][Full Text] [Related]
17. Detection of P. aeruginosa harboring bla CTX-M-2, bla GES-1 and bla GES-5, bla IMP-1 and bla SPM-1 causing infections in Brazilian tertiary-care hospital.
Polotto M; Casella T; de Lucca Oliveira MG; Rúbio FG; Nogueira ML; de Almeida MT; Nogueira MC
BMC Infect Dis; 2012 Aug; 12():176. PubMed ID: 22863113
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic and molecular detection of metallo-β-lactamase-producing Pseudomonas aeruginosa isolates from patients with burns in Tehran, Iran.
Azimi A; Peymani A; Pour PK
Rev Soc Bras Med Trop; 2018; 51(5):610-615. PubMed ID: 30304266
[TBL] [Abstract][Full Text] [Related]
19. Bloodstream infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: epidemiology, microbiology, and clinical outcomes.
Marra AR; Pereira CA; Gales AC; Menezes LC; Cal RG; de Souza JM; Edmond MB; Faro C; Wey SB
Antimicrob Agents Chemother; 2006 Jan; 50(1):388-90. PubMed ID: 16377720
[TBL] [Abstract][Full Text] [Related]
20. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary Health Region: importance of metallo-beta-lactamase (MBL)-producing strains.
Laupland KB; Parkins MD; Church DL; Gregson DB; Louie TJ; Conly JM; Elsayed S; Pitout JD
J Infect Dis; 2005 Nov; 192(9):1606-12. PubMed ID: 16206075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
